Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-042218
Filing Date
2008-02-29
Accepted
2008-02-28 19:54:52
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1428033
2 AFFILIATION AGREEMENT dex1014b.htm EX-10.14B 193554
3 REGISTRATION RIGHTS AGREEMENT dex1014g.htm EX-10.14G 78520
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 5829
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AS REQUIRED BY RULE 13A-14(A) dex311.htm EX-31.1 6034
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER AS REQUIRED BY RULE 13A-14(A) dex312.htm EX-31.2 8274
7 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER AS REQUIRED BY SECTION 1350 dex321.htm EX-32.1 3438
8 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER AS REQUIRED BY SECTION 1350 dex322.htm EX-32.2 5600
9 GRAPHIC g92825g64v42.jpg GRAPHIC 48933
10 GRAPHIC g92825g80r38.jpg GRAPHIC 108063
  Complete submission text file 0001193125-08-042218.txt   1947311
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 6506244900
TERCICA INC (Filer) CIK: 0001262175 (see all company filings)

EIN.: 260042539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50461 | Film No.: 08652475
SIC: 2834 Pharmaceutical Preparations